Post Offer Advertisement
ICICI Securities Limited ("Manager to the Offer") has submitted to BSE a copy of Post-offer advertisement, published by Procter & Gamble Overseas India B.V. ("the Acquirer") along with PAC, on December 4, 2018 ("Post-Offer Ad"). Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Merck Internationale Beteiligungen GmbH Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Emedia Export Company mit beschrankter Haftung Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chemitra Gesellschaft mit beschrankter Haftung Announcement Under Regulation 30
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and our announcement dated 28 November 2018, this is for the information of all concerned that Merck KGaA, Germany has announced today that closing under the share purchase and asset sale agreement entered into by it with The Procter & Gamble Company, amongst others, has taken place. Accordingly, closing under... Announcement under Regulation 30 (LODR)-Cessation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the following decisions taken at the meeting of the Board of Directors of the Company on 28 November 2018, all of which are conditional upon the consummation of the transactions contemplated by the India Sale and Purchase Agreement, dated April 19, 2018 (the 'India SAPA'), by and... Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations. 2015
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the following decisions taken at the meeting of the Board of Directors of the Company on 28 November 2018, all of which are conditional upon the consummation of the transactions contemplated by the India Sale and Purchase Agreement, dated April 19, 2018 (the 'India SAPA'), by and... CSIR lab, Merck set up life-sciences skilling centre
The centre will impart advanced competences and analytical skills required for life- sciences research to Indian students and researchers. Announcement Under Regulation 30
We have been informed today, on November 27, 2018 that the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, by a letter dated November 26, 2018, has approved the proposal dated July 2, 2018 of Merck Specialties Private Limited inter alia for acquisition of the biopharmaceuticals business of the Company by Merck Specialties Private Limited by way of a slump sale. We are making this announcement pursuant to... Outcome of Board Meeting
With reference to the above captioned subject, we are enclosing herewith a copy of un-audited Financial Results along with the Limited Review Report for the period ended September 30, 2018 as approved by the Board of Directors of the Company at its meeting held on October 30, 2018. The Un-audited Financial Results will be published in the newspapers within the stipulated time as per the SEBI Listing Regulations....